BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30126816)

  • 41. First-episode psychosis and vocational outcomes: A predictive model.
    Chua YC; Abdin E; Tang C; Subramaniam M; Verma S
    Schizophr Res; 2019 Sep; 211():63-68. PubMed ID: 31327504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study.
    Malla A; Norman R; Schmitz N; Manchanda R; Béchard-Evans L; Takhar J; Haricharan R
    Psychol Med; 2006 May; 36(5):649-58. PubMed ID: 16515734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of vocational activity over the first year in inner-city early intervention in psychosis services.
    Tapfumaneyi A; Johnson S; Joyce J; Major B; Lawrence J; Mann F; Chisholm B; Rahaman N; Wooley J; Fisher HL;
    Early Interv Psychiatry; 2015 Dec; 9(6):447-58. PubMed ID: 26104585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing.
    Ayesa-Arriola R; Pelayo Terán JM; Setién-Suero E; Neergaard K; Ochoa S; Ramírez-Bonilla M; Pérez-Iglesias R; Crespo-Facorro B
    Schizophr Res; 2019 Jul; 209():245-254. PubMed ID: 30772066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design.
    Kane JM; Schooler NR; Marcy P; Correll CU; Brunette MF; Mueser KT; Rosenheck RA; Addington J; Estroff SE; Robinson J; Penn DL; Robinson DG
    J Clin Psychiatry; 2015 Mar; 76(3):240-6. PubMed ID: 25830446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ten-year trajectory and outcomes of negative symptoms of patients with first-episode schizophrenia spectrum disorders.
    Chan SKW; Chan HYV; Pang HH; Hui CLM; Suen YN; Chang WC; Lee EHM; Chen EYH
    Schizophr Res; 2020 Jun; 220():85-91. PubMed ID: 32278539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.
    Schennach R; Riedel M; Obermeier M; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ
    Psychiatr Q; 2012 Jun; 83(2):187-207. PubMed ID: 22038270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does treatment delay in first-episode psychosis really matter?
    Harrigan SM; McGorry PD; Krstev H
    Psychol Med; 2003 Jan; 33(1):97-110. PubMed ID: 12537041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.
    Oliver D; Davies C; Crossland G; Lim S; Gifford G; McGuire P; Fusar-Poli P
    Schizophr Bull; 2018 Oct; 44(6):1362-1372. PubMed ID: 29373755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocol.
    Lutgens D; Iyer S; Joober R; Brown TG; Norman R; Latimer E; Schmitz N; Abdel Baki A; Abadi S; Malla A
    BMC Psychiatry; 2015 Feb; 15():22. PubMed ID: 25881022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Simonsen C; Faerden A; Romm KL; Berg AO; Bjella T; Sundet K; Ueland T; Andreassen O; Melle I
    Psychiatry Res; 2017 Aug; 254():118-125. PubMed ID: 28460281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of functioning in people suffering from first-episode psychosis 1 year into entering early intervention service in Hong Kong.
    Chong CS; Siu MW; Kwan CH; Chang WC; Lee EH; Chan SK; Hui CL; Tam FY; Chen EY; Lo WT
    Early Interv Psychiatry; 2018 Oct; 12(5):828-838. PubMed ID: 27731949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial.
    Schennach R; Riedel M; Obermeier M; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Spellmann I; Musil R; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):661-671. PubMed ID: 31463563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention.
    Ho RWH; Chang WC; Kwong VWY; Lau ESK; Chan GHK; Jim OTT; Hui CLM; Chan SKW; Lee EHM; Chen EYH
    Schizophr Res; 2018 May; 195():463-468. PubMed ID: 28888358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential impacts of duration of untreated psychosis (DUP) on cognitive function in first-episode schizophrenia according to mode of onset.
    Ito S; Nemoto T; Tsujino N; Ohmuro N; Matsumoto K; Matsuoka H; Tanaka K; Nishiyama S; Suzuki M; Kinoshita H; Ozawa H; Fujita H; Shimodera S; Kishimoto T; Matsumoto K; Hasegawa T; Mizuno M
    Eur Psychiatry; 2015 Nov; 30(8):995-1001. PubMed ID: 26497470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.
    Chang WC; Hui CL; Tang JY; Wong GH; Chan SK; Lee EH; Chen EY
    Psychol Med; 2013 Sep; 43(9):1883-93. PubMed ID: 23217676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis.
    Penttilä M; Jääskeläinen E; Hirvonen N; Isohanni M; Miettunen J
    Br J Psychiatry; 2014 Aug; 205(2):88-94. PubMed ID: 25252316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of a prospective, mixed methods study to assess feasibility, acceptability and effectiveness of TRIumPH (Treatment and Recovery In PsycHosis): an integrated care pathway for psychosis, compared to usual treatment.
    Rathod S; Thorne K; Graves E; Phiri P; Asher C; Griffiths A; Read T; Kingdon D
    BMJ Open; 2020 Apr; 10(4):e033711. PubMed ID: 32354777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.